Gupta R, Gaur K, Ram CVS. Emerging trends in hypertension epidemiology in India. J Hum Hypertens. 2019;33(8):575–87.
Article CAS PubMed Google Scholar
Geldsetzer P, Manne-Goehler J, Theilmann M, Davies JI, Awasthi A, Vollmer S, Jaacks LM, Bärnighausen T, Atun R. Diabetes and hypertension in India: a nationally representative study of 1.3 million adults. JAMA Intern Med. 2018;178(3):363–72.
Article PubMed PubMed Central Google Scholar
Pindiprolu SKS, Madhan J, Srinivasarao DA, Dasari N, Kumar CSP, Katta C, Jyothi VGS. Therapeutic targeting of aberrant sialylation for prevention of chemoresistance and metastasis in triple negative breast cancer. J Drug Deliv Sci Technol. 2023;86:104617.
Kakumani KV, Waingankar P. Assessment of compliance to treatment of diabetes and hypertension amongst previously diagnosed patients from rural community of Raigad district of Maharashtra. J Assoc Phys India. 2016;64(12):36–40.
Chintamaneni PK, et al. Engineered upconversion nanocarriers for synergistic breast cancer imaging and therapy: Current state of art. J Control Release. 2022;352:652–72.
Article CAS PubMed Google Scholar
Mohan V, Seedat YK, Pradeepa R. The rising burden of diabetes and hypertension in southeast asian and african regions: need for effective strategies for prevention and control in primary health care settings. Int J Hypertens. 2013;2013(1):409083.
PubMed PubMed Central Google Scholar
Devi P, et al. Prevalence, risk factors and awareness of hypertension in India: a systematic review. J Hum Hypertens. 2013;27(5):281–7.
Article CAS PubMed Google Scholar
Corsi DJ, Subramanian SV. Socioeconomic gradients and distribution of diabetes, hypertension, and obesity in India. JAMA Netw Open. 2019;2(4):e190411–e190411.
Article PubMed PubMed Central Google Scholar
Avery AJ, Bell BG. Rationalising medications through deprescribing. Br Med J Publ Group. 2019. https://doi.org/10.1136/bmj.l570
Aminabee S, et al. T. S. Pharmacoeconomic Analysis of Biologic vs. Biosimilar Therapies in Rheumatoid Arthritis.
Tripathy JP, et al. Prevalence and determinants of comorbid diabetes and hypertension: Evidence from non communicable disease risk factor STEPS survey, India. Diabetes Metab Syndr: Clin Res Rev. 2017;11:S459–65.
Radhakrishnan S, Ekambaram M. Prevalence of diabetes and hypertension among a tribal population in Tamil Nadu. Arch Med Health Sci. 2015;3(1):66–71.
Dasari N, Kumar CSP, Gummadi RK, Kiran Pindiprolu S. Application of novel natural sweetening agent-stevia in formulation, evaluation of nicardipine hydrochloride orodispersable tablets for rapid absorption. Ind J Pharm Edu Res. 2024;58(1s):s176–86.
Midha T, et al. Prevalence of hypertension in India: A meta-analysis. World J Meta-Anal. 2013;1(2):83–9.
Joshi SR, Parikh RM. India; the diabetes capital of the world: Now heading towards hypertension. J-Assoc Phys India. 2007;55(Y):323.
Dasari N, Guntuku GS, Pindiprolu SKS. Targeting triple negative breast cancer stem cells using nanocarriers. Discover Nano. 2024;19(1):41.
Article CAS PubMed PubMed Central Google Scholar
Gupta R, Ram CVS. Hypertension epidemiology in India: emerging aspects. Curr Opin Cardiol. 2019;34(4):331–41.
Gabert R, et al. Identifying gaps in the continuum of care for hypertension and diabetes in two Indian communities. BMC Health Serv Res. 2017;17:1–11.
Flor LS, et al. Community-based interventions for detection and management of diabetes and hypertension in underserved communities: a mixed-methods evaluation in Brazil, India, South Africa and the USA. BMJ Global Health. 2020;5(6):e001959.
Article PubMed PubMed Central Google Scholar
Dasari N, et al. Targeting angiogenesis with fluphenazine-zinc oxide nanoconjugates: A potential mechanism for improving antipsychotic efficacy. Int J App Pharm. 2023;15(5):339–43.
Chauhan S, et al. Urban-rural differential in diabetes and hypertension among elderly in India: A study of prevalence, factors, and treatment-seeking. Diabetes Metab Syndr: Clin Res Rev. 2021;15(4):102201.
Swami SS, et al. Hypertension and diabetes in India: a review. Int J Clin Biochem Res. 2015;2(1):54–8.
Joshi R, et al. Chronic diseases now a leading cause of death in rural India—mortality data from the Andhra Pradesh rural health initiative. Int J Epidemiol. 2006;35(6):1522–9.
UK Prospective Diabetes Study Group. UK prospective diabetes study 16: overview of 6 years’ therapy of type II diabetes: a progressive disease. Diabetes. 1995;44(11):1249–58.
Deepa M, et al. Knowledge and awareness of diabetes in urban and rural India: the Indian Council of Medical Research India diabetes study (phase I): Indian Council of Medical Research India diabetes 4. Indian J Endocrinol Metab. 2014;18(3):379–85.
Article CAS PubMed PubMed Central Google Scholar
Turner RC. The UK prospective diabetes study: a review. Diabetes Care. 1998;21(Supplement_3):C35–8.
Ramachandran A, Snehalatha C. Current scenario of diabetes in India. J Diabetes. 2009;1(1):18–28.
Gupta OP, Joshi MH, Dave SK. Prevalence of diabetes in India. Adv Metab Disord. 1978;9:147–65.
Article CAS PubMed Google Scholar
Mantri N, et al. National and regional prevalence of gestational diabetes mellitus in India: a systematic review and Meta-analysis. BMC Public Health. 2024;24(1):527.
Article PubMed PubMed Central Google Scholar
Kumar A, et al. Prevalence of diabetes in India: A review of IDF diabetes atlas 10th edition. Curr Diabetes Rev. 2024;20(1):105–14.
Basu S, et al. Prevalence and predictors of gestational diabetes mellitus and overt diabetes in pregnancy: A secondary analysis of nationwide data from India. Prev Med: Res Rev. 2024;1(1):52–8.
留言 (0)